Tag Archives: 2013 BIO International Convention

Scientific American Worldview Scorecard Correlates with International Investment

MikeMay

Biotechnology innovation requires investment, and the Scientific American Worldview Scorecard can predict where investment goes. A recent analysis indicates that the ranking of countries in this Scorecard correlates with global investment. As a result, the Worldview Scorecard provides a valuable tool for any country interested in increasing its appeal to biotechnology investors. In short, the Worldview Scorecard uses a wide collection of data – compiled and analyzed by Yali Friedman – that generates a metric Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Five Countries, One Goal: Collaboration with Global Impact in the Life Sciences Industry

MLSC

During the 2013 BIO International Convention, the Massachusetts Life Sciences Center (MLSC) and regions from four other countries launched the new International Collaborative Industry Program (ICIP). The MLSC will partner with Victoria, Australia; the Wallonia region of Belgium; Quebec, Canada; and Alsace in France to award funding to projects promoting innovative and collaborative research and development (R&D) between companies in Massachusetts and in the partnering regions. The program’s goal is to develop long-term collaborations to advance late-stage R&D projects in biotechnology, pharmaceuticals, medical Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

As biopharmaceutical manufacturers consider the new reality of accountable care organizations (ACOs) and the impact on their businesses, they must be ready to demonstrate the value of their products in ways that recognize the fine balance of cost and quality that ACO and ACO-like models seek to achieve. According to panelists speaking at the 2013 BIO International Convention session entitled, “Accountable Care Organization (ACO) Framework for Biopharmaceuticals,” there are three primary considerations when it comes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BioGENEius – From Student Participant to Judge

BioGENEius – From Student Participant to Judge

It’s been two years since I participated as a student in BioGENEius. Last year I presented my work at the White House Science Fair and now I am privileged to attend BioGENEius 2013 as a judge. BioGENEius 2013 is in Chicago this year and as a student at Northwestern University in nearby Evanston, I jumped at the chance to attend again. As I joined the judges and learned about their backgrounds, I felt honored to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

How to Drive International Innovation: Scientific American Worldview

Worldview Super Session

Which countries are winning the innovation game? Will the U.S. maintain its leadership position in the future? Have emerging markets lived up to the hype? Which new partnerships are transforming industries? For the fifth year, Scientific American (SA) released their Worldview: A Global Biotechnology Perspective report at the 2013 BIO International Convention in Chicago. Included in this year’s report is the longest list of country rankings that SA has ever compiled and the numbers reveal Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,